Concepedia

Publication | Open Access

T Lymphocyte Activation Markers as Predictors of Responsiveness to Rituximab among Patients with FSGS

36

Citations

40

References

2016

Year

Abstract

We have identified prognostic markers that define a subset of patients with FSGS bearing an immunologic signature representing hyporesponsiveness to T cell stimulation and therefore, who respond better to rituximab.

References

YearCitations

Page 1